In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
暂无分享,去创建一个
Amitava Mitra | Bart Hens | Bo Liu | Patrick Augustijns | Masoud Jamei | David B Turner | Shriram M Pathak | Nikunjkumar Patel | N. Patel | M. Jamei | B. Hens | P. Augustijns | J. Brouwers | A. Mitra | Joachim Brouwers | Sanjaykumar Patel | D. Turner | S. Pathak | Sanjaykumar Patel | Bo Liu | Bart Hens
[1] Kerby Shedden,et al. Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs. , 2017, Molecular pharmaceutics.
[2] J. Tack,et al. Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution. , 2017, International journal of pharmaceutics.
[3] Roelof J Bennink,et al. Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities. , 2017, International journal of pharmaceutics.
[4] J. Tack,et al. Exploring the link between gastric motility and intragastric drug distribution in man , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[5] B. Hens,et al. In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT. , 2016, International journal of pharmaceutics.
[6] M. Corsetti,et al. Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion. , 2016, Journal of pharmaceutical sciences.
[7] G. Amidon,et al. The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media. , 2016, Journal of pharmaceutical sciences.
[8] Rodrigo Cristofoletti,et al. Differences in Food Effects for 2 Weak Bases With Similar BCS Drug-Related Properties: What Is Happening in the Intestinal Lumen? , 2016, Journal of pharmaceutical sciences.
[9] K. Terada,et al. Effect of Seed Particles on Precipitation of Weak Base Drugs in Physiological Intestinal Conditions. , 2016, Molecular pharmaceutics.
[10] I. Kanfer,et al. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements , 2016, The AAPS Journal.
[11] R. Havenaar,et al. Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms. , 2016, International journal of pharmaceutics.
[12] P. Augustijns,et al. An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: Design, implementation, and evaluation. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[13] G. Amidon,et al. Gastrointestinal Motility Variation and Implications for Plasma Level Variation: Oral Drug Products. , 2016, Molecular pharmaceutics.
[14] Bart Hens,et al. Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans. , 2015, Journal of pharmaceutical sciences.
[15] H. Waskin,et al. Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects , 2014, Antimicrobial Agents and Chemotherapy.
[16] J. Dressman,et al. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] M. Corsetti,et al. Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] Martin C Garnett,et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. , 2014, Molecular pharmaceutics.
[19] Anette Müllertz,et al. In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] Martin Bergstrand,et al. PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] H Lennernäs,et al. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] H. Lennernäs,et al. Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Martin Culen,et al. Designing a dynamic dissolution method: a review of instrumental options and corresponding physiology of stomach and small intestine. , 2013, Journal of pharmaceutical sciences.
[24] M. Brewster,et al. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. , 2013, International journal of pharmaceutics.
[25] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[26] G. Amidon,et al. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen , 2012, Biopharmaceutics & drug disposition.
[27] Jan Tack,et al. The migrating motor complex: control mechanisms and its role in health and disease , 2012, Nature Reviews Gastroenterology &Hepatology.
[28] J. Tack,et al. Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole , 2011, Clinical pharmacokinetics.
[29] P. Vekilov,et al. The two-step mechanism of nucleation of crystals in solution. , 2010, Nanoscale.
[30] H. Lennernäs,et al. Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug , 2010, Pharmaceutical Research.
[31] Ulf Olsson,et al. Nucleation and crystal growth in supersaturated solutions of a model drug. , 2008, Journal of colloid and interface science.
[32] J. Dressman,et al. Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies , 2006, Pharmaceutical Research.
[33] F. Podczeck,et al. The use of formulation technology to assess regional gastrointestinal drug absorption in humans. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[34] J. Dressman,et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.
[35] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[36] A. Serajuddin,et al. Common ion effect on solubility and dissolution rate of the sodium salt of an organic acid , 1987, The Journal of pharmacy and pharmacology.